Simultaneous or rapid sequence initiation of medical therapies for heart failure: seeking to avoid the case of 'too little, too late'

Muhammad Shahzeb Khan¹, Javed Butler², Stephen J Greene^{1

3}

Affiliations

¹ Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.
² Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
³ Duke Clinical Research Institute, Durham, NC, USA.

Free article

Editorial

Muhammad Shahzeb Khan et al. Eur J Heart Fail. 2021 Sep.

Free article

. 2021 Sep;23(9):1514-1517.

doi: 10.1002/ejhf.2311. Epub 2021 Aug 4.

Muhammad Shahzeb Khan¹, Javed Butler², Stephen J Greene^{1

3}

¹ Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.
² Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
³ Duke Clinical Research Institute, Durham, NC, USA.

No abstract available

Comment on

Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
Savarese G, Bodegard J, Norhammar A, Sartipy P, Thuresson M, Cowie MR, Fonarow GC, Vaduganathan M, Coats AJS. Savarese G, et al. Eur J Heart Fail. 2021 Sep;23(9):1499-1511. doi: 10.1002/ejhf.2271. Epub 2021 Jun 28. Eur J Heart Fail. 2021. PMID: 34132001

1. Taylor CJ, Ordonez-Mena JM, Roalfe AK, Lay-Flurrie S, Jones NR, Marshall T, Hobbs FDR. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. BMJ 2019;364:l223.
1. Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, Killian JM, Roger VL. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med 2015;175:996-1004.
1. Greene SJ, Fonarow GC, DeVore AD, Sharma PP, Vaduganathan M, Albert NM, Duffy CI, Hill CL, McCague K, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Butler J. Titration of medical therapy for heart failure with reduced ejection fraction. J Am Coll Cardiol 2019;73:2365-2383.
1. Greene SJ, DeVore AD. The maximally tolerated dose: the key context for interpreting subtarget medication dosing for heart failure. JACC Heart Fail 2020;8:739-741.
1. Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, Hill CL, McCague K, Mi X, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Fonarow GC. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol 2018;72:351-366.